Medullary Thyroid Carcinoma Presenting as Metastatic Disease to the Breast

被引:3
|
作者
Kanteti, Archana P. [1 ]
Atiya, Samir [1 ]
Hein, Ashley [1 ]
Cox, Jesse L. [1 ]
Martinez Duarte, Ernesto [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA
关键词
TRANSCRIPTION FACTOR-I; NEUROENDOCRINE TUMORS; DIAGNOSTIC UTILITY; LUNG; PAX8;
D O I
10.1155/2020/6138409
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor that is derived from C cells of the thyroid gland. It is a rare aggressive tumor, known to metastasize to lymph nodes, liver, bones, and lungs. A 41-year-old female, who presented with a breast mass, was initially diagnosed with invasive ductal carcinoma. She was also found to have a thyroid mass which was later diagnosed as MTC. On a rereview of the breast pathology, the morphologic features were strikingly similar to the MTC. Further investigation revealed that this was in fact a very rare case of MTC that had metastasized to the breast. We have identified 20 cases of MTC metastasizing to the breast in the literature that supports its occurrence as a real possibility. Albeit rare, medullary thyroid carcinoma should be considered in the differential diagnosis of a breast mass.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Breast metastasis from medullary carcinoma of the thyroid
    Gargoura, Asma
    Khammassi, Naziha
    PAN AFRICAN MEDICAL JOURNAL, 2015, 22
  • [32] A misleading breast metastasis of medullary thyroid carcinoma
    Gardair, Charlotte
    Drabent, Philippe
    Charveriat, Patrick
    Bertheau, Philippe
    Cahen-Doidy, Laurence
    de Roquancourt, Anne
    ANNALES DE PATHOLOGIE, 2019, 39 (01) : 9 - 13
  • [33] Bilateral Breast Involvement in Medullary Thyroid Carcinoma
    Marcy, Pierre-Yves
    Thariat, Juliet
    Peyrottes, Isabelle
    Dassonville, Olivier
    THYROID, 2009, 19 (02) : 197 - 199
  • [34] Metastatic medullary thyroid carcinoma: a new way forward
    Angelousi, Anna
    Hayes, Aimee R.
    Chatzellis, Eleftherios
    Kaltsas, Gregory A.
    Grossman, Ashley B.
    ENDOCRINE-RELATED CANCER, 2022, 29 (07) : R85 - R103
  • [35] Rapid Response to Sorafenib in Metastatic Medullary Thyroid Carcinoma
    Frank-Raue, K.
    Ganten, M.
    Kreissl, M. C.
    Raue, F.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2011, 119 (03) : 151 - 155
  • [36] Use of capecitabine in refractory metastatic medullary thyroid carcinoma
    Eduardo Paiva, Carlos
    Carlito Michelin, Odair
    THYROID, 2008, 18 (05) : 587 - 587
  • [37] Aggressive bone marrow metastatic medullary thyroid carcinoma
    Lesesve, Jean-Francois
    Plenat, Francois
    BLOOD, 2014, 123 (17) : 2603 - 2603
  • [38] Systemic treatment of advanced, metastatic, medullary thyroid carcinoma
    Matrone, Antonio
    Gambale, Carla
    Prete, Alessandro
    Cappagli, Virginia
    Lorusso, Loredana
    Bottici, Valeria
    Elisei, Rossella
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2021, 7
  • [39] Metastatic Medullary Carcinoma of Thyroid Presenting as a Dural-Based Mass: Case Report and Review of Literature
    Rishi, Arvind
    Savona, Steven
    Black, Karen
    Schulder, Michael
    Li, Jian Yi
    ENDOCRINE PATHOLOGY, 2013, 24 (01) : 40 - 44
  • [40] Metastatic Medullary Carcinoma of Thyroid Presenting as a Dural-Based Mass: Case Report and Review of Literature
    Arvind Rishi
    Steven Savona
    Karen Black
    Michael Schulder
    Jian Yi Li
    Endocrine Pathology, 2013, 24 : 40 - 44